NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE99932 Query DataSets for GSE99932
Status Public on Nov 13, 2018
Title Loss of G9a preserves mutation patterns but increases chromatin accessibility, genomic instability and aggressiveness in skin tumours
Organism Mus musculus
Experiment type Expression profiling by array
Summary Mutations and expression changes of epigenetic modifiers are pervasive in human tumours, making epigenetic factors attractive as antitumour targets. However, the mutational landscape of tumours correlates with the chromatin state of their cell-of-origin, raising the concern that targeting epigenetic factors might alter the mutational burden and possibly aggravate disease progression. Nonetheless, a causal link between changes in chromatin in tissues and the mutational landscape of their cognate tumours has not yet been established. Here we show that increasing chromatin accessibility through a conditional deletion of the histone H3K9 methyltransferase G9a severely delays and reduces carcinogen-induced squamous tumour initiation and burden. Strikingly, after a prolonged latency, G9a-mutant mice develop highly aggressive tumours with an expanded cancer stem cell (SC) pool. Loss of G9a leads to extensive chromatin opening in the cells of origin of these tumours (i.e. epidermal and hair follicle SCs) . Although this does not alter the number of single-nucleotide variants, the type of substitutions, or the overall mutational topography, it significantly changes the mutational signatures (i.e. microcontext) in the tumor cells. G9a-depleted tumours also display pronounced genomic instability and a frequent accumulation of loss-of-function p53 mutations, compared to their wild-type counterparts. Our results therefore provide evidence for a causal link between chromatin modifications and mutational load in tumours and call for caution when assessing the long-term therapeutic benefits of inhibiting epigenetic factors.
 
Overall design Gene expression analysis of DMBA/TPA induced tumors in G9a WT and G9a cKO mice
 
Contributor(s) Avgustinova A, Symeonidi A, Solé L, Martín M, Castellanos A, Prats N, Supek F, Lehner B, Aznar Benitah S
Citation(s) 30455462
Submission date Jun 12, 2017
Last update date Jul 25, 2021
Contact name Aikaterini Symeonidi
E-mail(s) ksymeonidh@gmail.com
Organization name Institut for Research in Biomedicine (IRB-Barcelona)
Department Oncology
Lab Stem cells and Cancer Lab
Street address Baldiri i Reixac, 10
City Barcelona
State/province Barcelona
ZIP/Postal code 08028
Country Spain
 
Platforms (1)
GPL11180 [HT_MG-430_PM] Affymetrix HT MG-430 PM Array Plate
Samples (13)
GSM2664648 DMBA/TPA induced tumor in G9a WT mouse, replicate 2
GSM2664649 DMBA/TPA induced tumor in G9a WT mouse, replicate 4
GSM2664650 DMBA/TPA induced tumor in G9a WT mouse, replicate 6
This SubSeries is part of SuperSeries:
GSE99956 Loss of G9a preserves mutation patterns but increases chromatin accessibility, genomic instability and aggressiveness in skin tumours
Relations
BioProject PRJNA390166

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE99932_RAW.tar 28.6 Mb (http)(custom) TAR (of CEL)
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap